Psoriasis (PsO): Clinical Trials

39 trials for Psoriasis (PsO), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 recruiting, 11 not yet recruiting, 4 active not recruiting, 4 completed. 6 Not applicable, 4 Phase 1, 4 Phase 3, 3 Phase 2, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Active not recruiting 2, Recruiting 2, Completed 1, Not yet recruiting 1
Phase 14Recruiting 2, Completed 1, Not yet recruiting 1
Phase 34Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Phase 43Not yet recruiting 2, Recruiting 1
Early Phase 11Recruiting 1

Follow Psoriasis (PsO): new trials by email Literature Review of Psoriasis (PsO) trials Research Report on Psoriasis (PsO)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Definition of Novel Optoacoustic Biomarkers of Psoriasis and Psoriatic Arthritis
Raster-Scan Optoacoustic Mesoscopy, Multispectral Optoacoustic Tomography, Skin Biopsy and Skin Sample Collection - Psoriasis (PsO), Psoriasis Arthritis
Not applicableNot yet recruitingUniversity of Erlangen-Nürnberg Medical School1922026-10-072026-10-21
A Clinical Trial of Antiplatelets in Psoriasis
Aspirin, Clopidogrel, Placebo - Psoriasis (PsO), Psoriatic Arthritis (PsA)
Phase 4Not yet recruitingNYU Langone Health602026-09-012026-08-05
Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study.
OCTA-SCP, OCTA-DCP, OCTA-RPC - Arthritic Psoriasis, Psoriasis (PsO)
RecruitingBursa Yuksek Ihtisas Training and Research Hospital1352026-09-012026-10-13
A Study of HL40626S Tablets in Healthy Adults
HL40626S tablets, HL40626S placebo - Psoriasis (PsO), Skin Disease
Phase 1Not yet recruitingHighsLab Therapeutics Inc.642026-08-012026-08-03
Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis
Betamethasone Dipropionate 0.05% Cream, Tapinarof Cream 1% - Psoriasis (PsO)
Phase 4Not yet recruitingPakistan Institute of Medical Sciences1202026-08-012026-06-09
Inflammation Digital Biomarkers Validation Study
Psoriatic Arthritis, Psoriasis (PsO)
Not yet recruitingUniversity of Oxford34582026-06-012026-05-22
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
S-4321 - Autoimmune Diseases, Rheumatoid Arthritis (RA)
Phase 1RecruitingSeismic Therapeutic AU Pty Ltd242026-06-012026-06-01
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
Standard Maintenance, Non-standard Maintenance - Psoriasis, Psoriasis (PsO)
Not yet recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1202026-06-012026-06-11
Psoriasis Comorbidities at Hospital Calderón Guardia
Psoriasis, Psoriasis Arthritis
Not yet recruitingCaja Costarricense de Seguro Social3502026-05-012026-04-08
Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
Guselkumab (GUS), Risankizumab (RISA) - Psoriasis, Psoriasis Arthritis
Not yet recruitingCaja Costarricense de Seguro Social502026-05-012026-03-09
The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Music Therapy, Pink Noise - Psoriasis (PsO), Anxiety
Not applicableRecruitingUniversity of California, San Francisco1202026-02-012026-07-23
Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
No intervention - Psoriasis (PsO), Traditional Chinese Medicine (TCM)
Not yet recruitingShanghai Yueyang Integrated Medicine Hospital4502026-01-202026-01-20
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Semaglutide (Rybelsus®), Placebo - Psoriasis (PsO), Obesity & Overweight
Phase 4RecruitingHospital Universitario Dr. Jose E. Gonzalez622026-01-152026-02-11
Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy
Guselkumab Prefilled Syringe [Tremfya] - Psoriasis (PsO), PsA (Psoriatic Arthritis)
WithdrawnUniversity of California, San Diego2025-11-302026-02-23
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Psoriasis (PsO), Moderate to Severe Psoriasis
RecruitingChronicle Academy802025-11-252026-09-11
A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
XJH05 ointment, Calcipotriol ointment - Psoriasis, Psoriasis (PsO)
Not applicableRecruitingXijing Hospital32025-11-172026-10-13
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Offered an academic detailing session, Standard-of-care outreach from the insurance plan - Autoimmune Diseases, Rheumatoid Arthritis (RA)
Not applicableActive not recruitingBrigham and Women's Hospital13252025-11-062026-05-14
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Psoriasis (PsO), Psoriatic Arthritis (PsA)
RecruitingCharite University, Berlin, Germany5002025-09-222025-12-23
A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
Oral roflumilast - Psoriasis (PsO)
Phase 2RecruitingAhmed Ibrahim362025-08-202025-12-02
Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study
Probiotics and methotrexate, Methotrexate - Psoriasis (PsO)
Early Phase 1RecruitingAlexandria University242025-08-012025-09-11

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Psoriasis (39)  ·  Arthritis, Psoriatic (9)  ·  Dermatitis, Atopic (4)  ·  Arthritis, Rheumatoid (3)  ·  Autoimmune Diseases (3)  ·  Inflammatory Bowel Diseases (3)  ·  Anxiety Disorders (2)  ·  Colitis, Ulcerative (2)  ·  Obesity (2)  ·  Overweight (2)  ·  Spondylarthropathies (2)  ·  Abscess (1)  ·  Alcohol Drinking (1)  ·  Alopecia (1)  ·  Angioedema (1)

Broader conditions

Skin and Connective Tissue Diseases (39)  ·  Skin Diseases (38)  ·  Skin Diseases, Papulosquamous (38)  ·  Arthritis (11)  ·  Joint Diseases (11)  ·  Musculoskeletal Diseases (11)  ·  Bone Diseases (10)  ·  Spinal Diseases (10)  ·  Spondylarthritis (10)  ·  Spondylitis (10)  ·  Spondylarthropathies (8)  ·  Immune System Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Dermatitis (4)

Interventions

guselkumab (2)  ·  semaglutide (2)  ·  Acoustic Stimulation (1)  ·  Aspirin (1)  ·  Biological Factors (1)  ·  Clopidogrel (1)  ·  Complementary Therapies (1)  ·  Diet, Plant-Based (1)  ·  Dietary Fiber (1)  ·  Ethinyl Estradiol (1)  ·  Methotrexate (1)  ·  Music Therapy (1)  ·  Probiotics (1)  ·  Roflumilast (1)  ·  Tablets (1)

Sponsors

Caja Costarricense de Seguro Social (2)  ·  Charite University, Berlin, Germany (2)  ·  Shanghai Yueyang Integrated Medicine Hospital (2)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2)  ·  Xijing Hospital (2)  ·  Ahmed Ibrahim (1)  ·  Alexandria University (1)  ·  Alumis Inc (1)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Bursa Yuksek Ihtisas Training and Research Hospital (1)  ·  Chronicle Academy (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Grigore T. Popa University of Medicine and Pharmacy (1)  ·  Hansoh BioMedical R&D Company (1)

Countries

China (7)  ·  United States (6)  ·  Australia (3)  ·  Canada (3)  ·  Germany (3)  ·  Costa Rica (2)  ·  Egypt (2)  ·  Turkey (Türkiye) (2)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Estonia (1)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Abeer Mohamed Elkholy, MD Dermatology (1)  ·  Ezzeldin A. Saleh, PhD (1)  ·  Gamaleldin A. Elsawaf, PhD (1)  ·  Gang Wang (1)  ·  Giacomo Caldarola, MD (1)  ·  Jennifer Martin, MD (1)  ·  Julia-Tatjana Maul, Prof. Dr. med. (1)  ·  Laura Gheuca Solovastru (1)  ·  Man Ho Martin Chung (1)  ·  Michael Garshick, MD (1)  ·  Mohamed A. Alqasem, MSc (1)  ·  Vibeke Andersen, Prof (1)

Results publications

PMID 12228161, PMID 15002890, PMID 18259687, PMID 22224779, PMID 28588585, PMID 30387155, PMID 30793796, PMID 30928934, PMID 31298974, PMID 31453631, PMID 31595056, PMID 31899186, PMID 32022825, PMID 32365242, PMID 32427307, PMID 32852860, PMID 32888954, PMID 33531183, PMID 33812489, PMID 33926088, PMID 33995668, PMID 34769005, PMID 35304068, PMID 35513599, PMID 35601055, PMID 35988043, PMID 36653920, PMID 36917196, PMID 37908308, PMID 37953417, PMID 38470165, PMID 38699834, PMID 39055795, PMID 39459597, PMID 41319042

NIH funding

K23HL152013 (1)